Adipokine signaling in inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 15, Issue 12, 2009, Pages 1897-1905

  Batra, A ^a   Zeitz, M ^a   Siegmund, B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adipokines; Inflammatory bowel disease; Mucosal immune system

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APELIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN;

ADIPOCYTE; ADIPOSE TISSUE; CHRONIC INFLAMMATION; COMMENSAL; CROHN DISEASE; CYTOKINE PRODUCTION; DIETARY INTAKE; ENTERITIS; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; HYPERTROPHY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREGULATION; INCIDENCE; INTESTINE MUCOSA; INTRAABDOMINAL FAT; MACROPHAGE ACTIVATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MACROPHAGES; MALE; MICE; RATS; SIGNAL TRANSDUCTION;

EID: 72549093077     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20937     Document Type: Review

References (108)

1. Sheehan AL, Warren BF, Gear MW, et al. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg. 1992;79:955-958.
2. Maconi G, Greco S, Duca P, et al. Prevalence and clinical significance of sonographic evidence of mesenteric fat alterations in Crohn's disease. Inflamm Bowel Dis. 2008;14:1555-1561.
3. Barbier M, Vidal H, Desreumaux P, et al. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol Clin Biol. 2003;27:987-991. (Pubitemid 37516823)
4. Lin Y, Lee H, Berg AH, et al. The lipopolysaccharide-activated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem. 2000;275:24255-24263. (Pubitemid 30626513)
5. Batra A, Pietsch J, Fedke I, et al. Leptin-dependent toll-like receptor expression and responsiveness in preadipocytes and adipocytes. Am J Pathol. 2007;170:1931-1941. (Pubitemid 47339267)
6. Stroh T, Batra A, Glauben R, et al. Nucleotide oligomerization domains 1 and 2: regulation of expression and function in preadipocytes. J Immunol. 2008;181:3620-3627.
7. Cousin B, Munoz O, Andre M, et al. A role for preadipocytes as macrophage-like cells. FASEB J. 1999;13:305-312.
8. Villena JA, Cousin B, Penicaud L, et al. Adipose tissues display differential phagocytic and microbicidal activities depending on their localization. Int J Obes Relat Metab Disord. 2001;25:1275-1280. (Pubitemid 32835442)
9. Charriere G, Cousin B, Arnaud E, et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem. 2003;278:9850-9855. (Pubitemid 36800488)
10. Gay J, Tachon M, Neut C, et al. Mesenteric adipose tissue is colonized by bacterial flora and expresses pathogen recognition receptors in Crohn's disease. Gastroenterology. 2005;(suppl 2):A503.
11. Fruhbeck G. Overview of adipose tissue and its role in obesity and metabolic disorders. Methods Mol Biol. 2008;456:1-22.
12. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab. 2005;19:547-566.
13. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. FASEB J. 1998;12:57-65. (Pubitemid 28060271)
14. Lord GM, Matarese G, Howard JK, et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998;394:897-901. (Pubitemid 28410912)
15. Vaisse C, Halaas JL, Horvath CM, et al. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet. 1996;14:95-97. (Pubitemid 26301554)
16. Frederich RC, Lollmann B, Hamann A, et al. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest. 1995;96:1658-1663.
17. Madej T, Boguski MS, Bryant SH. Threading analysis suggests that the obese gene product may be a helical cytokine. FEBS Lett. 1995;373:13-18.
18. Zabeau L, Lavens D, Peelman F, et al. The ins and outs of leptin receptor activation. FEBS Lett. 2003;546:45-50. (Pubitemid 36782280)
19. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110:1093-1103.
20. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab. 1999;84:3686-3695. (Pubitemid 30645226)
21. Faggioni R, Jones-Carson J, Reed DA, et al. Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci U S A. 2000;97:2367-2372. (Pubitemid 30134075)
22. Siegmund B, Lear-Kaul KC, Faggioni R, et al. Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis. Eur J Immunol. 2002;32:552-560. (Pubitemid 34173346)
23. Siegmund B, Sennello JA, Jones-Carson J, et al. Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut. 2004;53:965-972. (Pubitemid 38824154)
24. Lord GM, Matarese G, Howard JK, et al. Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol. 2002;72:330-338.
25. Gainsford T, Willson TA, Metcalf D, et al. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci U S A. 1996;93:14564-14568. (Pubitemid 26419007)
26. Paul G, Schaffler A, Neumeier M, et al. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis. 2006;12:471-477. (Pubitemid 43916742)
27. Hartman HB, Hu X, Tyler KX, et al. Mechanisms regulating adipocyte expression of resistin. J Biol Chem. 2002;277:19754-19761. (Pubitemid 34967491)
28. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307-312. (Pubitemid 32151228)
29. McTernan PG, McTernan CL, Chetty R, et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab. 2002;87:2407. (Pubitemid 34521539)
30. Patel L, Buckels AC, Kinghorn IJ, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003;300:472-476. (Pubitemid 38375833)
31. Piestrzeniewicz K, Luczak K, Komorowski J, et al. Resistin increases with obesity and atherosclerotic risk factors in patients with myocardial infarction. Metabolism. 2008;57:488-493. (Pubitemid 351317962)
32. Azuma K, Katsukawa F, Oguchi S, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res. 2003;11:997-1001. (Pubitemid 41137512)
33. Perseghin G, Burska A, Lattuada G, et al. Increased serum resistin in elite endurance athletes with high insulin sensitivity. Diabetologia. 2006;49:1893-1900. (Pubitemid 44025044)
34. Kaser S, Kaser A, Sandhofer A, et al. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 2003;309:286-290. (Pubitemid 37025889)
35. Kusminski CM, da Silva NF, Creely SJ, et al. The in vitro effects of resistin on the innate immune signaling pathway in isolated human subcutaneous adipocytes. J Clin Endocrinol Metab. 2007;92:270-276.
36. Bokarewa M, Nagaev I, Dahlberg L, et al. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174:5789-5795. (Pubitemid 40593223)
37. Verma S, Li SH, Wang CH, et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation. 2003;108:736-740. (Pubitemid 36999260)
38. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.
39. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548-2556.
40. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930-1935. (Pubitemid 32472900)
41. Okamoto Y, Kihara S, Ouchi N, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2002;106:2767-2770. (Pubitemid 35396973)
42. Xu A, Wang Y, Keshaw H, et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest. 2003;112:91-100. (Pubitemid 38056380)
43. Neumeier M, Weigert J, Schaffler A, et al. Different effects of adiponectin isoforms in human monocytic cells. J Leukoc Biol. 2006;79:803-808. (Pubitemid 44835612)
44. Wang B, Trayhurn P. Acute and prolonged effects of TNF-alpha on the expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture. Pflugers Arch. 2006;452:418-427. (Pubitemid 43962051)
45. Wolf AM, Wolf D, Rumpold H, et al. Adiponectin induces the antiinflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun. 2004;323:630-635. (Pubitemid 39221142)
46. Tsatsanis C, Zacharioudaki V, Androulidaki A, et al. Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophys Res Commun. 2005;335:1254-1263. (Pubitemid 41215552)
47. Yamamoto K, Kiyohara T, Murayama Y, et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut. 2005;54:789-796. (Pubitemid 40732095)
48. Nishihara T, Matsuda M, Araki H, et al. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology. 2006;131:853-861. (Pubitemid 44307068)
49. Fayad R, Pini M, Sennello JA, et al. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology. 2007;132:601-614. (Pubitemid 46274660)
50. Pini M, Gove ME, Fayad R, et al. Adiponectin deficiency does not affect development and progression of spontaneous colitis in IL-10 knockout mice. Am J Physiol Gastrointest Liver Physiol. 2009;296:G382-387.
51. Gambero A, Marostica M, Abdalla Saad MJ, et al. Mesenteric adipose tissue alterations resulting from experimental reactivated colitis. Inflamm Bowel Dis. 2007;13:1357-1364. (Pubitemid 350206845)
52. Samal B, Sun Y, Stearns G, et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol. 1994;14:1431-1437. (Pubitemid 24984261)
53. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426-430. (Pubitemid 40139988)
54. Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, Janowska J, et al. Serum concentration of visfatin in obese women. Metabolism. 2007;56:1131-1134. (Pubitemid 47021180)
55. de Luis DA, Gonzalez Sagrado M, Conde R, et al. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients. Nutrition. 2008;24:517-521.
56. Revollo JR, Grimm AA, Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol. 2007;23:164-170. (Pubitemid 46192971)
57. Jia SH, Li Y, Parodo J, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest. 2004;113:1318-1327. (Pubitemid 39069931)
58. Ye SQ, Simon BA, Maloney JP, et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med. 2005;171:361-370.
59. Moschen AR, Kaser A, Enrich B, et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol. 2007;178:1748-1758. (Pubitemid 46154646)
60. Valentini L, Wirth EK, Schweizer U, et al. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition. 2009;25:172-181.
61. Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998;251:471-476. (Pubitemid 28505047)
62. Medhurst AD, Jennings CA, Robbins MJ, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem. 2003;84:1162-1172. (Pubitemid 36330668)
63. Taheri S, Murphy K, Cohen M, et al. The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun. 2002;291:1208-1212. (Pubitemid 34694318)
64. Kunduzova O, Alet N, Delesque-Touchard N, et al. Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes. FASEB J. 2008;22:4146-4153.
65. Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146:1764-1771. (Pubitemid 40396885)
66. Daviaud D, Boucher J, Gesta S, et al. TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J. 2006;20:1528-1530.
67. Han S, Wang G, Qiu S, et al. Increased colonic apelin production in rodents with experimental colitis and in humans with IBD. Regul Pept. 2007;142:131-137. (Pubitemid 46899240)
68. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2:367-373. (Pubitemid 44734225)
69. Van Harmelen V, Reynisdottir S, Eriksson P, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998;47:913-917. (Pubitemid 28255665)
70. Park KG, Park KS, Kim MJ, et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract. 2004;63:135-142. (Pubitemid 38096359)
71. Arner P. Regional differences in protein production by human adipose tissue. Biochem Soc Trans. 2001;29:72-75. (Pubitemid 32587481)
72. Demas GE. The energetics of immunity: a neuroendocrine link between energy balance and immune function. Horm Behav. 2004;45:173-180.
73. Long KZ, Nanthakumar N. Energetic and nutritional regulation of the adaptive immune response and trade-offs in ecological immunology. Am J Hum Biol. 2004;16:499-507. (Pubitemid 39199844)
74. Pond CM. Adipose tissue and the immune system. Prostaglandins Leukot Essent Fatty Acids. 2005;73:17-30.
75. Hikawyj-Yevich I, Spitzer JA. Endotoxin influence on lipolysis in isolated human and primate adipocytes. J Surg Res. 1977;23:106-113.
76. Khazen W, M'Bika JP, Collinet M, et al. Differentiation-dependent expression of interferon gamma and toll-like receptor 9 in 3T3-F442A adipocytes. Biochimie. 2007;89:669-675. (Pubitemid 46669779)
77. Vitseva OI, Tanriverdi K, Tchkonia TT, et al. Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity. 2008;16:932-937. (Pubitemid 351620468)
78. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70:845-857. (Pubitemid 34259301)
79. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606. (Pubitemid 32531409)
80. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603. (Pubitemid 32531408)
81. Saillan-Barreau C, Cousin B, Andre M, et al. Human adipose cells as candidates in defense and tissue remodeling phenomena. Biochem Biophys Res Commun. 2003;309:502-505. (Pubitemid 37083279)
82. Cancello R, Henegar C, Viguerie N, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005;54:2277-2286. (Pubitemid 41134253)
83. Curat CA, Wegner V, Sengenes C, et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia. 2006;49:744-747. (Pubitemid 43357549)
84. Mantovani A, Sica A, Locati M. New vistas on macrophage differentiation and activation. Eur J Immunol. 2007;37:14-16. (Pubitemid 46128780)
85. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity. 2005;23:344-346.
86. Lumeng CN, Deyoung SM, Bodzin JL, et al. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes. 2007;56:16-23.
87. Kucuk C, Sozuer E, Gursoy S, et al. Treatment with Met-RANTES decreases bacterial translocation in experimental colitis. Am J Surg. 2006;191:77-83. (Pubitemid 43042525)
88. Bassaganya-Rieraa J, Ferrera G, Casagrana O, et al. F4/80hiCCR2hi macrophage infiltration into the intra-abdominal fat worsens the severity of experimental IBD in obese mice with DSS colitis. e-SPEN, Eur e-Journal Clin Nutr Metab. 2009.
89. Desreumaux P, Ernst O, Geboes K, et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology. 1999;117:73-81. (Pubitemid 29297622)
90. Peyrin-Biroulet L, Chamaillard M, Gonzalez F, et al. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? Gut. 2007;56:577-583.
91. Cadwell K, Liu JY, Brown SL, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008;456:259-263.
92. Cummings JR, Cooney R, Pathan S, et al. Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene. Inflamm Bowel Dis. 2007;13:941-946. (Pubitemid 47309964)
93. Konrad A, Lehrke M, Schachinger V, et al. Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur J Gastroenterol Hepatol. 2007;19:1070-1074. (Pubitemid 350125378)
94. Colombel JF, Solem CA, Sandborn WJ, et al. Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut. 2006;55:1561-1567.
95. Fried SK, Appel B, Zechner R. Interleukin 1 alpha decreases the synthesis and activity of lipoprotein lipase in human adipose tissue. Horm Metab Res. 1993;25:129-130. (Pubitemid 23076202)
96. Hoene M, Weigert C. The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes Rev. 2008;9:20-29. (Pubitemid 350264626)
97. Mudter J, Neurath MF. Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis. 2007;13:1016-1023. (Pubitemid 47309974)
98. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92:347-355. (Pubitemid 40277057)
99. Esposito K, Giugliano G, Scuderi N, et al. Role of adipokines in the obesity-inflammation relationship: the effect of fat removal. Plast Reconstr Surg. 2006;118:1048-1057; discussion 1058-11049
100. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm. 2006;74:443-477.
101. Gustafson B, Hammarstedt A, Andersson CX, et al. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:2276-2283. (Pubitemid 350203940)
102. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008;93:S64-73.
103. Matarese G, La Cava A. The intricate interface between immune system and metabolism. Trends Immunol. 2004;25:193-200. (Pubitemid 38368167)
104. Brown RE. Could there be a fine-tuning role for brain-derived adipokines in the regulation of bodyweight and prevention of obesity? Mcgill J Med. 2008;11:177-184.
105. Revollo JR, Korner A, Mills KF, et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 2007;6:363-375. (Pubitemid 350011996)
106. Ognjanovic S, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol. 2002;187:1051-1058. (Pubitemid 35178410)
107. Masri B, Knibiehler B, Audigier Y. Apelin signalling: a promising pathway from cloning to pharmacology. Cell Signal. 2005;17:415-426. (Pubitemid 39643060)
108. Ding Q, Mracek T, Gonzalez-Muniesa P, et al. Identification of macrophage inhibitory cytokine-1 (MIC-1) in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology. 2008 (in press).